Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Joo Hyun Oh, Dong Hyun Sinn

Clin Mol Hepatol. 2023;29(3):820-820. Published online May 19, 2023

DOI: https://doi.org/10.3350/cmh.2023.0135

View: 1630 Download: 27

Jae Hwang Cha, Sang Ho Ra, Yu Mi Park, Yong Kwan Ji, Ji Hyun Lee, So Yeon Park, Soon Koo Baik, Sang Ok Kwon, Mee Yon Cho, Moon Young Kim

Clin Mol Hepatol. 2013;19(4):421-425. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.421

View: 7680 Download: 77 Crossref: 22

Yun Jung Kim, Byoung Kuk Jang, Eun Soo Kim, Kyung Sik Park, Kwang Bum Cho, Woo Jin Chung, Jae Seok Hwang

Clin Mol Hepatol. 2012;18(1):41-47. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.41

View: 7665 Download: 38 Crossref: 10

Hyoung Sik kim , Soo Taek Lee , Dae Gon kim , Deuk Soo Ahn

Clin Mol Hepatol. 1996;2(1):54-60.

View: 3478 Download: 101

1 |

Viewed By 5906	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5264	MAFLD: How is it different from NAFLD?
Viewed By 4976	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4068	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4047	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 137	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 104	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 82	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 71	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 66	MAFLD: How is it different from NAFLD?

Search